À retenir
Using data from 11 448 adults in Italy, the authors built age- and sex-specific percentile curves for handgrip strength and the five-repetition chair-stand test, showing a rise to a peak at 18-24 years, preservation at 25-44 and decline from 45 onwards. Participants were volunteers recruited at exhibitions, malls and health campaigns, so they may not mirror the whole population.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Low muscle strength predicts poor health outcomes and is a key part of sarcopenia, but without reference values for each age it is hard to judge one person's result. The authors wanted to produce normative values for upper and lower body strength across a wide range of ages.
Population et méthode
Cross-sectional analysis of the ongoing Longevity check-up (Lookup) 7+ project, run since June 2015 in unconventional settings across Italy (exhibitions, malls, health promotion campaigns). Adults aged 18+ who gave written informed consent were eligible. Upper-body strength was measured by handgrip and lower-body strength by the five-repetition chair-stand (5 × sit-to-stand) test. Smoothed centile curves for men and women from age 18 to 80+ were built with the lambda-mu-sigma method.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1From 1 June 2015 to 30 May 2019, 11 448 participants were enrolled. Mean age was 55.6 years (SD 11.5; range 18-98), and 6382 (56%) were women.
- 2The authors produced normative values for handgrip and the 5 × sit-to-stand test, both absolute and normalized by BMI, for men and women by age group.
- 3Strength across ages showed three periods: an increase to a peak in young age and early adulthood (18-24 years), preservation through midlife (25-44 years) and a decline from midlife onwards (45+ years).
Limites et incertitude
- 1Participants were self-selected volunteers at public events, with a mean age of 55.6 years, so the youngest and oldest groups probably have fewer people and less precise percentiles. The abstract does not give group sizes.
- 2The data are cross-sectional, so the age pattern compares different people at different ages rather than following the same people over time.
- 3The abstract does not report the actual cut-off values, and it does not test whether the percentiles predict health outcomes.
- 4This reading is based on the abstract only.
Mise en perspective
These curves let you see roughly where a grip or chair-stand result sits among people of the same age and sex. A low percentile is a reason to talk to a clinician about muscle health, not a diagnosis of sarcopenia. The decline from midlife onwards suggests that keeping up strength-related activity matters earlier than old age.
Vos données
Grip strength and the five-repetition chair stand can be repeated at home or at a clinic using the same method each time, and trends matter more than one result. Wearable data such as steps does not measure muscle strength, so these tests add information a tracker cannot give.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Low muscle strength is a powerful predictor of negative health-related events and a key component of sarcopenia. The lack of normative values for muscle strength across ages hampers the practical appraisal of this parameter. The aim of the present study was to produce normative values for upper and lower extremity muscle strength across a wide spectrum of ages, in a large sample of community-dwellers recruited in the Longevity check-up (Lookup) 7+ project.
Methods
Lookup 7+ is an ongoing project that started in June 2015 and conducted in unconventional settings (i.e. exhibitions, malls, and health promotion campaigns) across Italy with the aim of fostering the adoption of healthy lifestyles in the general population. Candidate participants are eligible for enrolment if they are 18+ years and provide written informed consent. Upper and lower extremity muscle strength is assessed by handgrip strength and five-repetition chair-stand [5 × sit-to-stand (STS)] tests, respectively. Cross-sectional centile and normative values for handgrip strength and 5 × STS tests from age 18 to 80+ years were generated for the two genders. Smoothed normative curves for the two tests were constructed for men and women using the lambda-mu-sigma method.
Results
From 1 June 2015 to 30 May 2019, 11 448 participants were enrolled. The mean age of participants was 55.6 years (standard deviation: 11.5 years; range: 18-98 years), and 6382 (56%) were women. Normative values for handgrip strength and the 5 × STS test, both absolute and normalized by body mass index, were obtained for men and women, stratified by age groups. Values of upper and lower extremity muscle strength across ages identified three periods in life: an increase to peak in young age and early adulthood (18-24 years), preservation through midlife (25-44 years), and a decline from midlife onwards (45+ years).
Conclusions
Our study established age-specific and gender-specific percentile reference values for handgrip strength and the 5 × STS test. The normative curves generated can be used to interpret the assessment of muscle strength in everyday practice for the early detection of individuals with or at risk of sarcopenia.
Sources et attribution
Normative values of muscle strength across ages in a 'real world' population: results from the longevity check-up 7+ project.
Landi F, Calvani R, Martone AM, Salini S, Zazzara MB, Candeloro M, Coelho-Junior HJ, Tosato M, Picca A, Marzetti E.
Journal of cachexia, sarcopenia and muscle · 2020-11-04
DOI: 10.1002/jcsm.12610 ↗PubMed · 33147374 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

